MustGrow Biologics Corp.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Corey J. Giasson
- Full Time Employees
- 8
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- 201 1st Avenue South Saskatoon SK Canada S7K 1J5
- IPO Date
- Jul 10, 2019
- Website
- mustgrow.ca
- Similar Companies
- Business
- MustGrow Biologics Corp. (TSXV: MGRO) develops and commercializes biological crop protection products derived from plant-based biochemistry, focusing on sustainable alternatives to chemical pesticides for the agriculture industry. The company offers TerraMG and previously offered BioFert, which utilize proprietary mustard-derived seed meal technology to deliver natural herbicides, pre-emergent herbicides, bio-stimulants, and fertilizers; these products target weeds, diseases, nematodes, and nutrient enhancement in crops such as corn, soybeans, wheat, potatoes, and vegetables. Operations span North America, with expansion into international markets including Europe, Asia, and South America; founded in 2014, MustGrow is headquartered in Saskatoon, Saskatchewan, Canada. In recent developments, MustGrow secured strategic distribution partnerships in key agricultural regions, including a 2024 agreement for TerraMG in the U.S. Midwest and expanded trials leading to commercial launches in Canada; the company also completed a financing round in late 2024 to support product registrations and scale-up manufacturing, alongside regulatory approvals for new formulations in multiple jurisdictions.
Company News
MustGrow Announces Officer Appointment and Grant of DSUs
MustGrow Biologics Corp. (MGRO:CA) Q2 2026 Earnings Call Transcript
MustGrow Announces Second Quarter 2026 Financial Results
Market One: MustGrow Biologics Receives First Bayer Milestone Payment
MustGrow Receives First Milestone Payment from Bayer AG
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
MustGrow Closes $3.7 Million Non-Brokered LIFE Offering
MustGrow Increases Non-Brokered LIFE Offering to Approximately $3.7 Million
MustGrow Announces First Quarter 2026 Financial Results
MustGrow Announces Non-Brokered LIFE Offering of Approximately $2 Million
MustGrow Biologics receives TerraSante approvals in Texas, Utah and Montana
MustGrow Receives Texas, Utah, and Montana Registrations for TerraSante(TM) Biofertility Product
Huawei Technologies unveils new design chip strategy amid intensifying global competition
MustGrow Announces Market Awareness Services and Investor Relations Agreements
Rivian beats earnings estimates amid R2 production ramp
Sandisk could blow past its own guidance as NAND pricing hits triple digits
MustGrow Biologics reports jump in revenue as TerraSante US sales drive growth
MustGrow Announces 2025 Financial Results
MustGrow wins Georgia approval for TerraSante biofertility product
MustGrow Receives Georgia Registration for TerraSante(TM) Biofertility Product